TSPAN6 and pancreatic adenocarcinoma: Importantly, low TSPAN6 expression also significantly correlated with poor survival in these pancreatic adenocarcinoma cohorts (p = 0.028 for GSE17891 and p = 0.001 for GSE11838) (Fig. 7d).